One 'Opdivo horror story' could be severe immune - related side effects. For example, some patients have experienced extreme fatigue that completely debilitates them, making it impossible to carry out normal daily activities. This is a real horror as it impacts their quality of life significantly.
One horror story could be a patient who had severe side effects from radiation therapy. He experienced extreme fatigue, skin burns that were very painful, and incontinence which greatly affected his quality of life.
One success story is of a patient named John. He had advanced lung cancer and was given Opdivo as a treatment option. After a few months of treatment, his tumor significantly shrank. His symptoms like shortness of breath and fatigue improved, and he was able to resume some of his normal daily activities.
One success story is of a breast cancer patient. She had been through various treatments with limited success. Then she tried DCA, and over time, her cancer markers in the blood decreased, indicating that the cancer was being held in check. It seems that DCA's effect on the cancer cell's metabolism was key here.
A breast cancer patient had a great success with capecitabine. Her cancer had spread to nearby lymph nodes. After capecitabine treatment, the spread was contained, and the primary tumor also shrank. This led to a reduction in the symptoms she was experiencing like pain and swelling in the breast area.
One success story is in leukemia treatment. CRISPR has been used to edit immune cells, like T - cells, to better target cancer cells. By making precise genetic modifications, these engineered T - cells can recognize and attack leukemia cells more effectively, leading to remission in some patients.
First, get second opinions. Different doctors may have different approaches or be more aware of potential side effects. Second, do thorough research on the treatment options available. Know the possible side effects in detail. For example, if considering radiation, understand how it can affect your body long - term.
There are success stories in patients with refractory colorectal cancer. Panitumumab has been able to control the disease progression in some of these difficult - to - treat cases. It works by blocking the EGFR pathway, which is often overactive in cancer cells. By doing so, it stops the cancer from growing and spreading, as seen in the cases where patients' symptoms improved and they had longer survival times.
One patient had a large liver tumor. After chemoembolization, the tumor shrank enough that other treatment options became available. It was a great success as it bought more time for the patient.
There are cases where patients with colorectal cancer that had spread to the liver had successful y90 treatment. The y90 particles were able to precisely target the cancer cells in the liver. As a result, the cancer growth was halted and in some cases, reversed. These patients had better survival rates and a better quality of life compared to those who did not receive the treatment. It's because y90 treatment is less invasive compared to some other options and can be very effective in the right cases.
Sure. There's a patient who had very little hope after being diagnosed with lung cancer. But with Opdivo, he started feeling better within weeks. His energy levels increased, and his cancer markers in blood tests started to decline.